NTLA Intellia Therapeutics, Inc. logo

NTLA Intellia Therapeutics, Inc.

Healthcare
$12.60+1.86%ClosedMarket Cap: $1.41B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

316

13F Shares

104,220,978

Ownership %

94.6%

New Positions

63

Increased Positions

163

Closed Positions

58

Reduced Positions

90

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
ARKGARK Genomic Revolution ETF2,917,6893.68%
ARKKARK Innovation ETF9,355,3302.10%
MOONDirexion Moonshot Innovators ETF15,2432.01%
WBIO LN10,9971.29%
WDNA LN10,6371.16%
GNOMGlobal X - Genomics & Biotechnology ETF45,0691.16%
BBCVirtus Biotech Clinical Trials ETF30,2301.07%
MEDXHorizon Kinetics Medical ETF13,1880.93%
XBI3,753,3330.63%
LABUDirexion Daily S&P Biotech Bull 3X ETF187,9470.50%
IDNAiShares Genomics Immunology and Healthcare ETF60,2610.49%
VMNFX152,1370.36%
HRTSTema Cardiovascular and Metabolic ETF14,0760.35%
KOMPState Street SPDR S&P Kensho New Economies Composite ETF329,8840.17%
PRFZInvesco RAFI US 1500 Small-Mid ETF370,3180.17%
VSTCX399,7610.15%
VSEQX1,574,2620.14%
IBBiShares Biotechnology ETF835,3370.13%
GINNGoldman Sachs Innovate Equity ETF15,9290.10%
AVSCX12,2750.10%